Navigation Links
GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD

The Food and Drug Administration. has given GlaxoSmithKline PLC's anti-seizure medicine to treat Primary Generalized Tonic-Clonic, or PGTC, the green signal.//

According to GlaxoSmithKline, the U.K. pharmaceutical company, the drug, Lamictal, has been approved to treat children age two and older, as well as adults.

PGTC seizures are said to be the most-serious and most-commonly occurring type of generalized seizures, seen in about 20% of patients with epilepsy.

Epilepsy is a recurrent, unprovoked seizure characterized by a change in sensation, awareness, or behavior which comes about by an electrical disturbance in the brain.

Lamictal has now received the fifth FDA approval. It been approved to treat partial and generalized seizures and as well as for use as maintenance therapy for adults with bipolar disorder.

The FDA's approval is said to have been based on a multicenter trial in pediatric and adult patients, which proved to be "highly effective" in reducing the frequency of generalized tonic-clonic seizures by 66%.


NLA
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
2. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
3. Researchers Scale to assess the Severity of Epilepsy in Kids
4. Epilepsy can be predicted
5. Epilepsy Drugs Can Enhance Risk of Birth Defects
6. Epilepsy Drug Helps Diabetic Nerve Damage
7. Epilepsy Drug May Relieve Chronic Headaches
8. More Complications Seen In Women With Epilepsy
9. Epilepsy Drugs Found To Lead To Bone Loss
10. Another Use For Epilepsy Drugs
11. Epilepsy Patients Could Benefit From Pacemakers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... MA (PRWEB) , ... January 24, 2017 , ... American ... in Bedford, expanding access to high-quality health care for residents in the area. The ... fourth location opened during the past four years by Dave Adams and Dr. Kristina ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... supplement for relieving premenstrual syndrome, or PMS . , Most women of ... symptoms can include cramps, constipation, irritability, headaches, fatigue, and other discomfort. For ...
(Date:1/24/2017)... ... January 24, 2017 , ... “Who Would Have Dreamed: A Novel of Miracles”: a beautiful ... tried to understand its purpose in her life. “Who Would Have Dreamed: A Novel of ... and a love of writing. , Sharon shares that she started her spiritual ...
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual ... Octagon of Spiritual Balances” is the creation of published author, Pastor Bernard J. Weathers, ... Weathers holds a bachelor degree in religious education and a master degree in theology. ...
(Date:1/24/2017)... (PRWEB) , ... January 23, 2017 , ... ... refined coffee house-caliber protein and espresso drink, announced its CLICK® Coffee Protein Drink ... , CLICK® Coffee Protein Drink Mix has become popular among health-conscious consumers who ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... , January 24, 2017 The global  active pharmaceutical ... billion by 2025, based on a new report by Grand View Research, ... projected to drive the market over the forecast period. Advancements in recombinant ... estimated to boost growth.  Continue Reading ... ...
(Date:1/24/2017)... YORK , Jan. 23, 2017 ... detect, and control light. The interaction of these ... used in a wide range of applications. These ... aerospace and defense, telecommunications, and healthcare among others. ... primarily owing to its low power consumption, reliability, ...
(Date:1/24/2017)... , Jan. 23, 2017 The global peripheral ... 2015, and it is expected to grow at a ... catheter segment accounted for larger share in the global ... the various end users, the hospital segment accounted for ... same year. The global peripheral I.V. catheter market is ...
Breaking Medicine Technology: